Miao Fangfang, Feng Kunpeng, Feng Xuexin, Fan Long, Lang Yu, Duan Qingfang, Hou Ruixue, Jin Di, Wang Tianlong
Department of Anesthesiology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Front Pharmacol. 2021 Feb 22;12:631897. doi: 10.3389/fphar.2021.631897. eCollection 2021.
Patients experience moderate-high intensity postoperative pain after cesarean section (CS). The aim of this study was to investigate the optimal concentrations of ropivacaine and sufentanil for use in controlling pain after CS. One hundred and seventy-four women undergoing elective CS were randomly allocated to four groups. Epidural analgesia was administered with 0.1% ropivacaine in the R group, 0.15% ropivacaine in the R group, a combination of 0.1% ropivacaine and 0.5 μg/ml of sufentanil in the RS group, and a combination of 0.15% ropivacaine and 0.5 μg/ml of sufentanil in the RS group (at a basal rate of 4 ml/h, bolus dose of 4 ml/20 min as needed). Pain scores (numerical rating scale [NRS]: 0-10 cm) at rest (NRS-R), during movement (NRS-M), and when massaging the uterus (NRS-U) were documented at 6 and 24 h. We also recorded patient satisfaction scores, time to first flatus, motor deficits, and adverse drug reactions. NRS (NRS-R, NRS-M, NRS-U) scores in the RS group (2 [1-3], 4 [3-5], 6 [5-6], respectively) were lower than in the R group (3 [3-4], 5 [4-6], 7 [6-8], respectively) ( < 0.001, < 0.05, < 0.01, respectively) at 6 h; and patient satisfaction (9 [8-10]) was improved compared to the R group (8 [6-8]) ( < 0.01). The time to first flatus (18.7 ± 11.8 h) was reduced relative to the R group (25.9 ± 12.0 h) ( < 0.05). The time to first ambulation was not delayed ( > 0.05). However, the incidence of pruritus (4 [9.3%]) was increased compared to the R group (0 [0]) ( < 0.05) at 6 h, and the incidence of numbness (23 [53.5%], 23 [53.5%]) was increased compared to the R group (10 [23.3%], 10 [23.3%]) (all < 0.01) at both 6 and 24 h. Although we observed a higher incidence of pruritus and numbness, co-administration of 0.15% ropivacaine and 0.5 μg/ml of sufentanil administered epidurally optimized pain relief after CS, with treated subjects exhibiting lower NRS scores, shorter time to first flatus, and higher patient-satisfaction scores.
剖宫产术后患者会经历中高强度的疼痛。本研究旨在探讨用于控制剖宫产术后疼痛的罗哌卡因和舒芬太尼的最佳浓度。174例行择期剖宫产的女性被随机分为四组。R组采用0.1%罗哌卡因进行硬膜外镇痛,RR组采用0.15%罗哌卡因,RS组采用0.1%罗哌卡因与0.5μg/ml舒芬太尼联合使用,RR组采用0.15%罗哌卡因与0.5μg/ml舒芬太尼联合使用(基础速率为4ml/h,按需推注剂量为4ml/20min)。分别在6小时和24小时记录静息时(NRS-R)、活动时(NRS-M)和按摩子宫时(NRS-U)的疼痛评分(数字评分量表[NRS]:0 - 10cm)。我们还记录了患者满意度评分、首次排气时间、运动功能障碍和药物不良反应。RS组在6小时时的NRS(NRS-R、NRS-M、NRS-U)评分(分别为2[1 - 3]、4[3 - 5]、6[5 - 6])低于R组(分别为3[3 - 4]、5[4 - 6]、7[6 - 8])(分别为<0.001、<0.05、<0.01);与R组(8[6 - 8])相比,患者满意度(9[8 - 10])得到改善(<0.01)。首次排气时间(18.7±11.8小时)相对于R组(25.9±12.0小时)缩短(<0.05)。首次下床活动时间未延迟(>0.05)。然而,RS组在6小时时瘙痒发生率(4[9.3%])高于R组(0[0])(<0.05),在6小时和24小时时麻木发生率(23[53.5%]、23[53.5%])均高于R组(10[23.3%]、10[23.3%])(均<0.01)。尽管我们观察到瘙痒和麻木的发生率较高,但硬膜外联合使用0.15%罗哌卡因和0.5μg/ml舒芬太尼可优化剖宫产术后的疼痛缓解,治疗组患者的NRS评分更低、首次排气时间更短且患者满意度评分更高。